Adirex Pharmaceuticals Private Limited, a active private limited company, was established on 12 October 2015 in Gurugram, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900HR2015PTC056936. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹4.00 M.
It upholds a compliant status. Employing 25 professional, Its leadership includes Rekha Dandapat (Director), Debkumar Dandapat (Director). Past directors included Sirin Sekh, Monali Datta. It holds ₹1.81 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 77A/5, Phase-5 Gurugram, Gurugram, Haryana, 122016.
U74900HR2015PTC056936
056936
12 October 2015
₹4.00 M
₹4.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Adirex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rekha Dandapat | Director | 12 Oct 2015 | Current |
| Debkumar Dandapat | Director | 10 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Sep 2018 | Past |
| Pramod Abcsdd | Director | 10 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Adirex Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.41% decrease. The company also saw a slight decrease in profitability, with a 7.26% decrease in profit. The company's net worth Soared by an impressive increase of 23.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Adirex Pharmaceuticals had a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹18,100,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2024 | Uco Bank | ₹1.30 M | Open |
| 18 Oct 2022 | Uco Bank | ₹1.50 Cr | Open |
| 23 Nov 2020 | Others | ₹1.80 M | Open |
Explore comprehensive loan charge details -
Adirex Pharmaceuticals has a workforce of 25 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Adirex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adirex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Uco Bank amounted to Rs. 1.30 M with Charge ID 101004670 was registered on 28 Oct 2024. was documented.
Adirex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Adirex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Uco Bank amounted to Rs. 15.00 M with Charge ID 100619414 was registered on 18 Oct 2022. was completed.
A charge with Others amounted to Rs. 1.80 M with Charge ID 100419907 was registered on 23 Nov 2020. was recorded as a recent event.
The activity Debkumar Dandapat was appointed as a Director was appointed as a Director on 10 Sep 2018 & has been associated with this company since 7 years 2 months . was completed.
The CIN of Adirex Pharmaceuticals Private Limited is U74900HR2015PTC056936.
Adirex Pharmaceuticals Private Limited is headquartered at 77A/5, Phase-5 Gurugram, Gurugram, Haryana, 122016.
Adirex Pharmaceuticals Private Limited was incorporated on 12 October 2015.
The current directors of Adirex Pharmaceuticals Private Limited are
The primary industry of Adirex Pharmaceuticals Private Limited is Trade.
Adirex Pharmaceuticals Private Limited is unlisted.
The authorized capital of Adirex Pharmaceuticals Private Limited is ₹4.00 M, and the paid-up capital is ₹4.00 M.
The compliance status of Adirex Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX